HomeMeetings Past Meetings 2017 SUO at the AUA Program Viewer

Past Meetings

SUO 2017 Annual Meeting At the AUA

May 13, 2017
Program Chair: Scott E. Eggener, MD
Novel Management Approaches

DateTimeSession
GENERAL SESSION  
13
Sat
12:30 p.m. - 12:40 p.m.
State of Affairs of the SUO/Welcome
President:
Leonard G. Gomella, MD, FACS
President-Elect:
Christopher Paul Evans, MD, FACS
13
Sat
12:40 p.m. - 12:45 p.m.
Welcome and Introduction
Program Chairs:
Scott E. Eggener, MD

James Michael McKiernan, MD
13
Sat
12:45 p.m. - 12:55 p.m.
Introduction to the Whitmore Lecture
Speaker:
Leonard G. Gomella, MD, FACS
13
Sat
12:55 p.m. - 1:15 p.m.
Whitmore Lecture: Triage to SPORE - The Variable Slope of Success and How Opportunity Manifests
Speaker:
Colin P.N. Dinney, MD
13
Sat
1:15 p.m. - 2:30 p.m.
Prostate Cancer: Screening and Diagnostic Biomarkers
Session Chair:
Peter Robert Carroll, MD, MPH
13
Sat
1:15 p.m. - 1:25 p.m.
Best Prostate Cancer Papers from the Past Year
Speaker:
Mark A. Preston, MD, MPH
13
Sat
1:25 p.m. - 1:40 p.m.
Genetic Testing in Inherited Prostate Cancer Risk: Consensus Statement
Speaker:
Veda Giri
13
Sat
1:40 p.m. - 1:55 p.m.
Reflex Testing with Serum, Urine, and Tissue Biomarkers - Which, When and How Valuable?
Speaker:
Stacy Loeb, MD, MSc
13
Sat
1:55 p.m. - 2:10 p.m.
Multiparametric MRI - When, Who, and How to Interpret?
Moderator:
Peter Robert Carroll, MD, MPH
13
Sat
 
European Perspective
Speaker:
Caroline Moore, MBBS MD FRCS
13
Sat
 
United States Perspective
Speaker:
Peter Anthony Pinto, MD
13
Sat
 
Questions from Moderator
13
Sat
2:10 p.m. - 2:30 p.m.
Panel: How I Screen
13
Sat
 
EAU View
Speaker:
Nicolas Mottet, MD, PhD
13
Sat
 
NCCN View
Speaker:
John Kellogg Parsons, MD, MHS
13
Sat
 
AUA View
Speaker:
H. Ballentine Carter, MD
13
Sat
 
Asia View
Speaker:
Kazuto Ito, MD, PhD
13
Sat
2:30 p.m. - 2:40 p.m.
Break
13
Sat
2:40 p.m. - 2:45 p.m.
SUO & AUA Prostate Cancer Foundation Award
Speaker:
Stuart Holden, MD
13
Sat
2:45 p.m. - 2:50 p.m.
SUO Awards
Speaker:
Leonard G. Gomella, MD, FACS
13
Sat
2:50 p.m. - 4:10 p.m.
Bladder Cancer: Novel Treatment for Today and the Future
Session Chair:
Sam S. Chang, MD, MBA
13
Sat
2:50 p.m. - 2:58 p.m.
Best Urothelial Cancer Papers from 2016
Speaker:
Anne K. Schuckman, MD
13
Sat
2:58 p.m. - 3:06 p.m.
Beyond Cytology: What is the Urinary Marker We Should Use Now and What Will Be the Best in the Future?
Speaker:
Kristen R. Scarpato, MD, MPH
13
Sat
3:06 p.m. - 3:14 p.m.
What is the Best Imaging and What Will We Be Using in the Future: Cystoscopy and Cross Sectional Imaging?
Speaker:
Joseph C. Liao, MD
13
Sat
3:14 p.m. - 3:26 p.m.
What is the Best Systemic Therapy for Metastatic/Invasive Bladder Cancer?
13
Sat
 
Chemotherapy
Speaker:
Gopa Iyer, MD
13
Sat
 
Immunotherapy/Other
Speaker:
Arjun Balar, MD
13
Sat
3:26 p.m. - 3:38 p.m.
High Risk Non-Muscle Invasive Bladder Cancer
13
Sat
 
BCG
Speaker:
Wassim Kassouf, MD, CM, FRCSC
13
Sat
 
BCG and Check Point Inhibitors
Speaker:
Charles Drake, MD, PhD
13
Sat
3:38 p.m. - 3:50 p.m.
Non-Muscle Invasive Bladder Cancer Guidelines
13
Sat
 
European
Speaker:
Maria J. Ribal, MD, PhD
13
Sat
 
American
Speaker:
Stephen Anthony Boorjian, MD
13
Sat
3:50 p.m. - 4:10 p.m.
Panel Discussion - Clinical Bladder Cancer Quandaries: What to Do Today and in the Future?
Moderator:
Sam S. Chang, MD, MBA
Panelists:
Cheryl T. Lee, MD

Juan Palou, MD, PhD

Wade J. Sexton, MD

Gary David Steinberg, MD
13
Sat
4:10 p.m. - 5:00 p.m.
Kidney Cancer: Accurate Diagnosis and Targeted Treatment
Session Chair:
Antonio Finelli, MD
13
Sat
4:10 p.m. - 4:20 p.m.
Best Kidney Cancer Papers from Past Year
Speaker:
Alexander Kutikov, MD, FACS
13
Sat
4:20 p.m. - 4:30 p.m.
Role of Biopsy in the Management of Small Renal Masses
Speaker:
Tracey L. Krupski, MD, MPH
13
Sat
4:30 p.m. - 4:40 p.m.
Cystic Renal Masses: Radiographic Assessment and Management
Speaker:
Vincenzo Ficarra, MD, FEBU
13
Sat
4:40 p.m. - 4:50 p.m.
The Role of Neoadjuvant and Adjuvant Systemic Therapy in RCC
Speaker:
Mohamad Ezzedine Allaf, MD
13
Sat
4:50 p.m. - 5:00 p.m.
The Reemergence of Immunotherapy in RCC and Novel Clinical Trials
Speaker:
Lauren C. Harshman, MD
13
Sat
5:00 p.m. - 5:00 p.m.
Adjourn